Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated with Mayzent (siponimod): An OTIS Observational Pregnancy Surveillance Study

21/06/2021
18/07/2024
EU PAS number:
EUPAS41495
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

BAF312A2403 - final draft 3 protocol - for submission - Clean version_Redacted

English (1.05 MB - PDF) View document
Updated protocol

BAF312A2403 - final protocol V1.1 - for submission - Clean_Redacted

First published: 22/02/2024
English (940.31 KB - PDF) View document
Study results
Study report
Other information